Trust Co. of Oklahoma Decreases Stake in The Cigna Group (NYSE:CI)

Trust Co. of Oklahoma cut its holdings in shares of The Cigna Group (NYSE:CI) by 2.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,711 shares of the health services provider’s stock after selling 114 shares during the quarter. Trust Co. of Oklahoma’s holdings in The Cigna Group were worth $1,301,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CI. Ulland Investment Advisors LLC lifted its stake in shares of The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after buying an additional 100 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in The Cigna Group during the 3rd quarter valued at $37,000. ORG Wealth Partners LLC purchased a new stake in shares of The Cigna Group during the fourth quarter worth $34,000. Harbor Capital Advisors Inc. bought a new position in shares of The Cigna Group in the third quarter worth $45,000. Finally, Intact Investment Management Inc. purchased a new position in shares of The Cigna Group in the third quarter valued at $69,000. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Price Performance

CI opened at $289.04 on Thursday. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $80.40 billion, a P/E ratio of 27.27, a PEG ratio of 0.78 and a beta of 0.54. The stock has a 50-day moving average price of $298.30 and a 200-day moving average price of $326.03. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83.

The Cigna Group (NYSE:CI) last issued its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.22 by $0.29. The business had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The Cigna Group’s revenue for the quarter was up 29.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.77 earnings per share. Equities analysts predict that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CI has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft cut their target price on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Piper Sandler reaffirmed an “overweight” rating and set a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Royal Bank of Canada decreased their target price on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, Truist Financial decreased their price target on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $395.93.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.